Inovio Pharmaceuticals
INO
INO
125 hedge funds and large institutions have $184M invested in Inovio Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $176M → $184M (+$8.52M)
0.18% more ownership
Funds ownership: 2.5% → 2.69% (+0.18%)
Holders
125
Holding in Top 10
–
Calls
$2.27M
Puts
$1.2M
Top Buyers
| 1 | +$10.1M | |
| 2 | +$7.72M | |
| 3 | +$3.75M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.51M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.33M |
Top Sellers
| 1 | -$760K | |
| 2 | -$688K | |
| 3 | -$629K | |
| 4 |
Goldman Sachs
New York
|
-$594K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$334K |